Botanix Pharmaceuticals Ltd.
 
 
 
 
公司概覽
業務類別 --
業務概覽 Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.
公司地址 41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
電話號碼 +61 865552945
傳真號碼 +61 862101153
公司網頁 https://www.botanixpharma.com
員工數量 10
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Dr. Patricia S. Walker, M.D.,PhD Director 29/08/2025
Dr. Stewart Washer Director 29/08/2025
Dr. William Bosch Director 29/08/2025
Mr. Vincent Ippolito Executive Chairman of the Board 29/08/2025
 
所屬ETF (更新日期: 07/03/2026 04:12)
代號 名稱 佔比% 持有日期
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.03%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.01%27/02/2026
DFAIDimensional International Cr Eq Mkt ETF0.01%27/02/2026
DFICDimensional International Core Eq 2 ETF0.003%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.